Mossoba, Miriam E <br/><br/>
Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2.  [electronic resource] 

 -  Molecular therapy : the journal of the American Society of Gene Therapy  Mar 2008 
 - 607-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-0024 
<br/><br/><label>Standard No.: </label>10.1038/sj.mt.6300390  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CD4-Positive T-Lymphocytes--cytology<br/>CD8-Positive T-Lymphocytes--cytology<br/>Cancer Vaccines--genetics<br/>Cell Line, Tumor<br/>Cytokines--metabolism<br/>Dendritic Cells--immunology<br/>Female<br/>Flow Cytometry<br/>Genetic Therapy--methods<br/>Green Fluorescent Proteins--genetics<br/>Immunotherapy, Adoptive--methods<br/>Killer Cells, Natural--cytology<br/>Lentivirus--genetics<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Prostatic Neoplasms--genetics<br/>Receptor, ErbB-2--genetics<br/>Recombinant Fusion Proteins--genetics<br/>Spleen--cytology<br/>Transduction, Genetic<br/>Vaccination--methods